Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Jul 07, 2021 10:45am
65 Views
Post# 33505053

plitheone i agree prometics patented plasma fractionation

plitheone i agree prometics patented plasma fractionation tech   is much better than the fifty year old cohn's process   it will become the gold standard and they sold it for peanuts     and did this two weeks before fda approval    

can't wait to see what defendants say during discovery    kory sorenson didn't quit just before takeover for nothing   what will other defendants say under oath like louise menard  sartore, etc

what will lynne gagnon say as witness,pierre laurin,john moran, 
lawyers are obtaining correspondance between fda and prometic  
<< Previous
Bullboard Posts
Next >>